- Home
- MAX vs ORIC Comparison
MAX vs ORIC Comparison
Compare MAX & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAX
- ORIC
- Stock Information
- Founded
- MAX 2014
- ORIC 2014
- Country
- MAX United States
- ORIC United States
- Employees
- MAX N/A
- ORIC N/A
- Industry
- MAX Industrial Machinery/Components
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MAX Industrials
- ORIC Health Care
- Exchange
- MAX Nasdaq
- ORIC Nasdaq
- Market Cap
- MAX 582.4M
- ORIC 362.9M
- IPO Year
- MAX 2020
- ORIC 2020
- Fundamental
- Price
- MAX $10.98
- ORIC $10.31
- Analyst Decision
- MAX Buy
- ORIC Strong Buy
- Analyst Count
- MAX 7
- ORIC 8
- Target Price
- MAX $17.21
- ORIC $18.83
- AVG Volume (30 Days)
- MAX 397.9K
- ORIC 1.3M
- Earning Date
- MAX 07-30-2025
- ORIC 08-11-2025
- Dividend Yield
- MAX N/A
- ORIC N/A
- EPS Growth
- MAX N/A
- ORIC N/A
- EPS
- MAX 0.28
- ORIC N/A
- Revenue
- MAX $1,002,364,000.00
- ORIC N/A
- Revenue This Year
- MAX $24.09
- ORIC N/A
- Revenue Next Year
- MAX $11.18
- ORIC N/A
- P/E Ratio
- MAX $39.69
- ORIC N/A
- Revenue Growth
- MAX 148.62
- ORIC N/A
- 52 Week Low
- MAX $7.33
- ORIC $3.90
- 52 Week High
- MAX $20.91
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MAX 60.72
- ORIC 71.78
- Support Level
- MAX $10.60
- ORIC $8.85
- Resistance Level
- MAX $11.09
- ORIC $10.99
- Average True Range (ATR)
- MAX 0.36
- ORIC 0.69
- MACD
- MAX -0.04
- ORIC 0.01
- Stochastic Oscillator
- MAX 59.22
- ORIC 77.10
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.